LONG-TERM UPREGULATION OF MIR-124 IN BLOOD AND RECTAL BIOPSIES OF PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS RECEIVING OBEFAZIMOD 50 MG DAILY FOR 96-WEEKS

Julien Santo  1     AurĂ©lien Flatres  1     Paul GINESTE  2     Didier scherrer  2     Josianne Nitcheu  2     Sheldon Sloan  2     Hartmut Ehrlich  2     Bruce E. Sands  3     Severine Vermeire  4    
1 Abivax, Montpellier, France
2 Abivax, Paris, France
3 Icahn School of Medicine at Mount Sinai, New York, United States
4 University Hospitals Leuven, Leuven, Belgium

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing